miR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression
Open Access
- 25 April 2024
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-19
Abstract
Colorectal cancer (CRC), recognized among the five most prevalent malignancies and most deadly cancers, manifests multifactorial influences stemming from environmental exposures, dietary patterns, age, and genetic predisposition. Although substantial progress has been made in comprehending the etiology of CRC, the precise genetic components driving its pathogenesis remain incompletely elucidated. Within the expansive repertoire of non-coding RNAs, particular focus has centered on the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs, which actively participate in diverse cellular processes and frequently exhibit heightened expression in various solid tumors, notably CRC. Therefore, the primary objective of this research is to undertake an extensive inquiry into the regulatory mechanisms, structural features, functional attributes, and potential diagnostic and therapeutic implications associated with this cluster in CRC. Furthermore, the intricate interplay between this cluster and the development and progression of CRC will be explored. Our findings underscore the upregulation of the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs in CRC compared to normal tissues, thus implying their profound involvement in the progression of CRC. Collectively, these molecules are implicated in critical oncogenic processes, encompassing metastatic activity, regulation of apoptotic pathways, cellular proliferation, and drug resistance. Consequently, these findings shed illuminating insights into the potential of MIR17HG and its associated miRNAs as promising targets for therapeutic interventions in the management of CRC. Graphical abstractKeywords
This publication has 92 references indexed in Scilit:
- Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumorsClinical and Experimental Medicine, 2022
- MiR-17-3p Facilitates Aggressive Cell Phenotypes in Colon Cancer by Targeting PLCD1 Through Affecting KIF14Applied Biochemistry and Biotechnology, 2022
- SOX4 induces drug resistance of colorectal cancer cells by downregulating CYLD through transcriptional activation of microRNA‐17Journal of Biochemical and Molecular Toxicology, 2021
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- lncRNA MCM3AP‐AS1 inhibits the progression of colorectal cancer via the miR‐19a‐3p/FOXF2 axisThe Journal of Gene Medicine, 2021
- miR‐20a inhibits hypoxia‐induced autophagy by targeting ATG5/FIP200 in colorectal cancerMolecular Carcinogenesis, 2019
- A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1Cancer Medicine, 2016
- ggplot22016
- Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancerHuman Mutation, 2012
- mir-17-92, a cluster of miRNAs in the midst of the cancer networkThe International Journal of Biochemistry & Cell Biology, 2010